Microcarriers Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Microcarriers Market size was valued at USD 1.8 billion in 2023 and is anticipated to register a CAGR of over 9.5% between 2024 and 2032. The high market growth can be attributed to factors such as increasing cases of cancer and chronic diseases along with the advancements in cell culture technologies.
Also, rising investments in biotechnology & life sciences research activities, increasing focus on regenerative medicine, global need for vaccine production, and expanding stem cell therapy based research are few of the other factors driving the market growth. For instance, according to the WCRF International, there were an estimated 18.1 million cancer cases around the world in 2020.
The cancer research involving the cultivation and study of cancer cells in vitro to understand their behaviour, response to treatments, and molecular characteristics is expected to be on surge. Thus, microcarriers provide a platform for the efficient growth and expansion of cancer cells, supporting research efforts aimed at advancing to understand the disease, thereby driving the growth of the market.
Microcarriers are small, typically spherical particles or beads designed for use in cell culture and bioprocessing applications. These particles provide a surface for the attachment and growth of anchorage-dependent cells, allowing for the expansion of cell populations in a controlled environment. They are commonly used in bioreactors and other cell culture systems to support the production of cells for various purposes, including the manufacturing of biopharmaceuticals, vaccines, and cell-based therapies.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Microcarriers Market size in 2023: | USD 1.8 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2023 - 2032 CAGR: | 9.5 |
2023 Value Projection: | USD 4 Billion |
Historical Data for: | 2018 - 2023 |
No of Pages: | 230 |
Tables, Charts & Figures: | 518 |
Segments Covered: | Products, Application, End-user, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
However, the concerns relate to the interaction between microcarriers, and the cells cultured on them, as well as the potential immune response when microcarriers are introduced into living organisms. Thus, biocompatibility and immunogenicity concerns represent potential pitfalls for the market.
Based on product, the market is bifurcated into consumables and equipment. The consumables segment held the largest business share of 67.5% in 2023.
Based on application, the microcarrier market is classified into biopharmaceutical production, regenerative medicine, and other applications. The biopharmaceutical production is expected to exhibit 9.6% CAGR between 2024 and 2032.
Based on end-user, the microcarrier market is divided into pharmaceutical & biotechnology companies, CROs & CMOs, academic & research institutes, and cell banks. The pharmaceutical & biotechnology companies’ segment is expected to reach the largest market revenue of USD 1.6 billion by 2032.
In 2023, North America held a significant share of 40.7% in the microcarriers market.
The microcarriers industry is characterized by diverse players competing in the industry. Thermo Fisher Scientific Inc., Sartorious AG, Merck KGaA, and Corning Incorporated account for significant market share. These prominent players adopt a combination of strategic initiatives to provide comprehensive range of products, such as collaboration & partnership, global expansion, research and development, market access and commercialization, product diversification, and regulatory compliance to maintain a competitive edge in the market.
Foremost players operating in the microcarriers industry are as mentioned below:
The microcarriers market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:
Market, By Product
Market, By Application
Market, By End-user
The above information is provided for the following regions and countries:
The global microcarriers industry was valued at USD 1.8 billion in 2023 and is estimated to grow at a CAGR of 9.5% during the forecast period to reach USD 4 billion by 2032, driven by increasing cancer cases.
The biopharmaceutical production segment is expected to exhibit 9.6% CAGR between 2024-2032, as microcarriers provide a platform for efficient and scalable cell culture, supporting the growth of cells needed to produce biopharmaceuticals.
The size of the North America Microcarrier Market was valued at USD 730.1 million in 2023 and is expected to reach USD 1,602.3 million by 2032.
Bio-Rad Laboratories, Inc., Corning Incorporated, Cytiva, denovoMATRIX GmbH, Eppendorf AG, Fujiform Holdings Corporation, Lonza Group Ltd., Merck KGaA, Sartorious AG and Thermo Fisher Scientific Inc.